SCHEDULE: ULSE Inc. & Underwriters Labs Maintain 61.6% Stake in UL Solutions

ULSE Inc. and Underwriters Laboratories Inc. jointly report beneficial ownership of 61.6% of UL Solutions Inc.'s Class A Common Stock through convertible Class B shares.

Summary

• ULSE Inc. and Underwriters Laboratories Inc. (the "Reporting Persons") jointly filed an Amendment No. 1 to Schedule 13G.
• The Reporting Persons beneficially own an aggregate of 123,755,000 shares of UL Solutions Inc.
• This represents 61.6% of the Class A Common Stock, calculated based on 77,257,235 Class A shares outstanding as of December 19, 2025, plus the 123,755,000 convertible Class B shares.
• The owned shares are Class B common stock, convertible at any time on a one-for-one basis into Class A common stock.
• Both Reporting Persons hold shared voting and dispositive power over these 123,755,000 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-slightly positive filing, primarily confirming a stable, significant ownership structure. It doesn't introduce new risks or opportunities but reinforces the existing control by the parent entities, which can be seen as a stabilizing factor.

Positives

• The significant ownership stake (61.6%) by ULSE Inc. and Underwriters Laboratories Inc. indicates a stable, long-term controlling interest in UL Solutions Inc.

Negatives

• No specific negative financial or operational information is disclosed in this beneficial ownership report.

Risks

• No specific risks related to UL Solutions Inc.'s operations or financial health are disclosed in this beneficial ownership report.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant beneficial ownership stakes, often by institutional investors or, in this case, a parent entity. The substantial 61.6% stake held by ULSE Inc. and Underwriters Laboratories Inc. suggests a continued controlling interest, which is common for companies that have recently gone public or have a complex ownership structure involving a founding or parent organization. This type of filing primarily provides transparency on ownership structure rather than operational or competitive insights.

Corporate Governance

Stakeholder Impact

• Shareholders: The significant majority ownership by ULSE Inc. and Underwriters Laboratories Inc. implies that strategic decisions for UL Solutions Inc. will largely be influenced by these entities, potentially ensuring stability but also limiting the influence of minority shareholders.
• Management: The governance structure of the controlling entities, where no single individual has sole voting or investment discretion, suggests a collective oversight approach for UL Solutions Inc.'s management.

Key Dates

Recommendation

This Schedule 13G filing primarily provides transparency on the beneficial ownership structure of UL Solutions Inc., confirming that ULSE Inc. and Underwriters Laboratories Inc. maintain a substantial 61.6% stake. It does not contain new financial performance data, strategic updates, or material changes that would warrant a change in investment recommendation. The stable, controlling ownership by these entities suggests a degree of long-term stability, but without further operational or financial details, a "hold" recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

UL Solutions Inc., ULSE Inc., Underwriters Laboratories Inc., Schedule 13G, Beneficial Ownership, Class A Common Stock, Class B Common Stock, Equity Stake, Institutional Ownership, SEC Filing